المؤلفون: B. Kuhn, Xiaoping Zhang, AJ Kivitz, Christophe Schmitt, Susan Grange

المصدر: Clinical Pharmacology & Therapeutics. 89:735-740

مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, Simvastatin, medicine.medical_specialty, Arthritis, Bioequivalence, Antibodies, Monoclonal, Humanized, Gastroenterology, Arthritis, Rheumatoid, chemistry.chemical_compound, Tocilizumab, Pharmacokinetics, Internal medicine, medicine, Humans, Drug Interactions, Pharmacology (medical), skin and connective tissue diseases, Aged, Pharmacology, biology, Interleukin-6, business.industry, Antibodies, Monoclonal, Middle Aged, Drug interaction, medicine.disease, Endocrinology, chemistry, Antirheumatic Agents, Rheumatoid arthritis, HMG-CoA reductase, biology.protein, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33652234e10b6c544ec6fefaf3274307
https://doi.org/10.1038/clpt.2011.35

المؤلفون: Deodhar A; Oregon Health & Science University, Portland, OR, USA., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA., Magrey M; University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Walsh JA; Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Salt Lake City, UT, USA., Mease PJ; Swedish Medical Center/Providence St Joseph Health and University of Washington, Seattle, WA, USA., Greenwald M; Desert Medical Advances, Palm Desert, CA, USA., Kianifard F; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Elam C; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Bommidi GM; Novartis Healthcare Pvt Ltd, Hyderabad, India., Winseck A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Gensler LS; University of California, San Francisco, San Francisco, CA, USA.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Aug 12. Date of Electronic Publication: 2024 Aug 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

المؤلفون: Kivitz AJ; Altoona Center for Clinical Research/Altoona Arthritis and Osteoporosis Center, 175 Meadowbrook Lane, PO Box 1018, Duncansville, PA, 16635, USA. ajkivitz@yahoo.com., Kremer JM; The Center for Rheumatology, Albany, NY, USA., Legerton CW 3rd; Low Country Rheumatology/Articularis Healthcare, North Charleston, SC, USA., Pricop L; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Singhal A; Southwest Rheumatology, Dallas, TX, USA.

المصدر: Rheumatology and therapy [Rheumatol Ther] 2024 Jun; Vol. 11 (3), pp. 675-689. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE

المؤلفون: Baraf HSB; Rheumatology, Center for Rheumatology and Bone Research, Wheaton, MD, USA.; Rheumatology, George Washington University, Washington DC, USA., Khanna PP; Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA., Kivitz AJ; Department of Rheumatology, Altoona Center for Clinical Research, Duncansville, PA, USA., Strand V; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA., Choi HK; Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, USA., Terkeltaub R; Rheumatology, Allergy and Immunology Division, San Diego VA Healthcare Service and UCSD, San Diego, CA, USA., Dalbeth N; Bone and Joint Research Group, Department of Medicine, University of Auckland, Auckland, New Zealand., DeHaan W; Selecta Biosciences, Watertown, MA, USA., Azeem R; Selecta Biosciences, Watertown, MA, USA., Traber PG; Selecta Biosciences, Watertown, MA, USA., Keenan RT; Duke University School of Medicine, Durham, NC, USA.; Arthrosi Therapeutics, San Diego, CA, USA.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Apr 02; Vol. 63 (4), pp. 1058-1067.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Gout* , Stomatitis*/chemically induced , Stomatitis*/drug therapy, Adult ; Humans ; Gout Suppressants/adverse effects ; Gout Suppressants/therapeutic use ; Polyethylene Glycols/adverse effects ; Polyethylene Glycols/therapeutic use ; Symptom Flare Up ; Treatment Outcome ; Urate Oxidase/therapeutic use ; Urate Oxidase/adverse effects ; Uric Acid ; Uricosuric Agents/adverse effects ; Uricosuric Agents/therapeutic use

المؤلفون: Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin, Berlin, Germany., Strand V; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA., Kivitz AJ; Department of Rheumatology, Altoona Center for Clinical Research, Duncansville, PA, USA., Hu CC; Sanofi, Bridgewater, NJ, USA., Wang S; Sanofi, Bridgewater, NJ, USA., van Hoogstraten H; Sanofi, Bridgewater, NJ, USA., Klier GL; Sanofi, Bridgewater, NJ, USA., Fleischmann R; University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, TX, USA.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Oct 03; Vol. 62 (10), pp. 3268-3279.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/chemically induced , Antirheumatic Agents*/adverse effects , Neutropenia*/epidemiology, Humans ; Antibodies, Monoclonal, Humanized/adverse effects ; Treatment Outcome ; Methotrexate/therapeutic use

المؤلفون: Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Matsubara T; Department of Orthopedics, Matsubara Mayflower Hospital, Kato, Hyogo, Japan., Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan., Amano K; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Hidaka, Saitama, Japan., Ishiguro N; Aichi Developmental Disability Center, Kasugai, Aichi, Japan., Sugiyama E; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan., Combe BG; Rheumatology Department, CHU Montpellier, Montpellier University, Montpellier, France., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA., Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology Research and Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea., Keystone EC; Department of Medicine, University of Toronto, Toronto, ON, Canada., Nash P; Griffith University of Queensland, Brisbane, Queensland, Australia., Genovese M; Gilead Sciences Inc., Foster City, CA, USA., Matzkies F; Gilead Sciences Inc., Foster City, CA, USA., Bartok B; Gilead Sciences Inc., Foster City, CA, USA., Pechonkina A; Gilead Sciences Inc., Foster City, CA, USA., Kondo A; Gilead Sciences K.K., Tokyo, Japan., Ye L; Gilead Sciences Inc., Foster City, CA, USA., Gong Q; Gilead Sciences Inc., Foster City, CA, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, and Saitama Medical University, Iruma, Saitama, Japan.

المصدر: Modern rheumatology [Mod Rheumatol] 2023 Jul 04; Vol. 33 (4), pp. 668-679.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Antirheumatic Agents*/adverse effects , Antirheumatic Agents*/therapeutic use , Arthritis, Rheumatoid*/drug therapy , Janus Kinase Inhibitors*/therapeutic use, Animals ; Humans ; Adalimumab/therapeutic use ; Double-Blind Method ; Drug Therapy, Combination ; East Asian People ; Janus Kinase 1 ; Methotrexate/adverse effects ; Methotrexate/therapeutic use ; Treatment Outcome

المؤلفون: Combe BG; Montpellier University, Montpellier, France. b-combe@chu-montpellier.fr.; Rheumatology Department, Lapeyronie Hospital, Montpellier University, 34295, Montpellier Cedex 5, France. b-combe@chu-montpellier.fr., Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Buch MH; NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, UK., Nash P; Griffith University of Queensland, Brisbane, Australia., Burmester GR; Charité University Hospital Berlin, Berlin, Germany., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA., Bartok B; Gilead Sciences, Inc., Foster City, CA, USA., Pechonkina A; Gilead Sciences, Inc., Foster City, CA, USA., Xia K; Gilead Sciences, Inc., Foster City, CA, USA., Emoto K; Gilead Sciences K.K., Tokyo, Japan., Kano S; Gilead Sciences K.K., Tokyo, Japan., Hendrikx TK; Galapagos NV, Mechelen, Belgium., Landewé RBM; Amsterdam Rheumatology and Clinical Immunology Center (amC) and Zuyderland MC, Heerlen, The Netherlands., Aletaha D; Medical University of Vienna, Vienna, Austria.

المصدر: Rheumatology and therapy [Rheumatol Ther] 2023 Feb; Vol. 10 (1), pp. 53-70. Date of Electronic Publication: 2022 Oct 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE

المؤلفون: Combe BG; Montpellier University, Montpellier, France. b-combe@chu-montpellier.fr.; Rheumatology Department, Lapeyronie Hospital, Montpellier University, 34295, Montpellier Cedex 5, France. b-combe@chu-montpellier.fr., Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Buch MH; NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, UK., Nash P; Griffith University of Queensland, Brisbane, Australia., Burmester GR; Charité University Hospital Berlin, Berlin, Germany., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA., Bartok B; Gilead Sciences, Inc., Foster City, CA, USA., Pechonkina A; Gilead Sciences, Inc., Foster City, CA, USA., Xia K; Gilead Sciences, Inc., Foster City, CA, USA., Emoto K; Gilead Sciences K.K., Tokyo, Japan., Kano S; Gilead Sciences K.K., Tokyo, Japan., Hendrikx TK; Galapagos NV, Mechelen, Belgium., Landewé RBM; Amsterdam Rheumatology and Clinical Immunology Center (amC) and Zuyderland MC, Heerlen, The Netherlands., Aletaha D; Medical University of Vienna, Vienna, Austria.

المصدر: Rheumatology and therapy [Rheumatol Ther] 2023 Feb; Vol. 10 (1), pp. 71-72.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE

المؤلفون: Baraliakos X; Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany., Deodhar A; Oregon Health & Science University, Portland., Dougados M; Université de Paris, Department of Rheumatology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, INSERM U1153, Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Gensler LS; Department of Rheumatology, University of California, San Francisco., Molto A; Université de Paris, Department of Rheumatology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, INSERM U1153, Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Ramiro S; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, and Department of Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, Pennsylvania., Poddubnyy D; Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Oortgiesen M; UCB Pharma, Raleigh, North Carolina., Vaux T; UCB Pharma, Slough, UK., Fleurinck C; UCB Pharma, Brussels, Belgium., Shepherd-Smith J; UCB Pharma, Slough, UK., de la Loge C; UCB Pharma, Brussels, Belgium., de Peyrecave N; UCB Pharma, Brussels, Belgium., van der Heijde D; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2022 Dec; Vol. 74 (12), pp. 1943-1958. Date of Electronic Publication: 2022 Nov 07.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Spondylitis, Ankylosing*/drug therapy , Spondylitis, Ankylosing*/chemically induced, Humans ; Quality of Life ; Double-Blind Method ; Antibodies, Monoclonal, Humanized/therapeutic use ; Treatment Outcome

المؤلفون: Abuqayyas L; Amgen Inc., Thousand Oaks, California., Cheng LE; Amgen Inc., South San Francisco, California., Teixeira Dos Santos M; Amgen Inc., Thousand Oaks, California., Sullivan BA; Amgen Inc., South San Francisco, California., Ruiz-Santiago N; Amgen Inc., Thousand Oaks, California., Wang H; Amgen Inc., Thousand Oaks, California., Zhou Y; Amgen Inc., South San Francisco, California., Chindalore V; Pinnacle Research Group, Anniston, Alabama., Cohen S; Metroplex Clinical Research Center, Dallas, Texas., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, Pennsylvania., Posch MG; Charité Research Organisation GmbH, Berlin, Germany., Parnes JR; Amgen Inc., Thousand Oaks, California.

المصدر: ACR open rheumatology [ACR Open Rheumatol] 2022 Oct; Vol. 4 (10), pp. 903-911. Date of Electronic Publication: 2022 Jul 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101740025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-5745 (Electronic) Linking ISSN: 25785745 NLM ISO Abbreviation: ACR Open Rheumatol Subsets: PubMed not MEDLINE